A phase I study of the pharmacokinetics, pharmacodynamics, and safety of single- and multiple-dose anastrozole in healthy, premenopausal female volunteers

Abstract

Anastrozole was well tolerated and suppressed E2 levels, with a resultant increase in FSH.